Anzeige
Mehr »
Login
Mittwoch, 18.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Megachance: Aktien-Geheimtipp aus der 2. Reihe - der Markt schläft nicht!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A402W5 | ISIN: US3179701012 | Ticker-Symbol:
NASDAQ
18.12.24
20:15 Uhr
2,660 US-Dollar
-0,140
-5,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
FIREFLY NEUROSCIENCE INC Chart 1 Jahr
5-Tage-Chart
FIREFLY NEUROSCIENCE INC 5-Tage-Chart

Aktuelle News zur FIREFLY NEUROSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAIFF-Aktie erreicht 52-Wochen-Tief bei 2,69 US-Dollar1
04.12.Firefly Neuroscience, Inc.: Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman1
04.12.FIREFLY NEUROSCIENCE, INC. - S-1/A, General form for registration of securities-
03.12.FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report-
15.11.Firefly Neuroscience reports Q3 results1
FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln
14.11.Firefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update81Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's...
► Artikel lesen
06.11.Firefly Neuroscience, Inc.: Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event1
01.11.FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report1
25.10.Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)169TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve...
► Artikel lesen
21.10.Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data9
16.10.Firefly Neuroscience, Inc.: Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA Technology168TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve...
► Artikel lesen
15.10.Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder107TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve...
► Artikel lesen
04.10.AIFF-Aktie erreicht 52-Wochen-Tief bei 2,74 US-Dollar1
04.10.AIFF stock touches 52-week low at $2.74 amid market challenges1
27.09.Firefly Neuroscience files to sell 2.56M shares for holders1
27.09.FIREFLY NEUROSCIENCE, INC. - S-1, General form for registration of securities1
26.09.AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges1
20.09.Firefly Neuroscience, Inc.: Firefly Neuroscience Advances AI-Driven BNA Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis16
11.09.Zeto inks partnership with Firefly Neuroscience1
10.09.Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA Technology with Zeto's FDA-Cleared EEG Device Platform1
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1